SCHEMBL29294119

SCHEMBL29294119

FC(F)(F)c1cc(-c2cccc3c2sc2c(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)cccc23)cc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 4/20 0.45
▸ EGFR P00533 2/20 0.45
▸ FGFR1 P11362 2/20 0.45
▸ CYP11B1 P15538 3/20 0.43
▸ CYP11B2 P19099 3/20 0.43
▸ NPY5R Q15761 1/20 0.43
▸ PIM1 P11309 2/20 0.41
▸ CYP2A6 P11509 2/20 0.39
▸ KCNH2 Q12809 2/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ DGAT1 O75907 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CKS1B P61024 1/20 0.38
▸ SKP2 Q13309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29293971 0.94 KDR (0.48) KDREGFRFGFR1CYP11B1CYP11B2
SCHEMBL29295362 0.94 KDR (0.48) KDREGFRFGFR1CYP11B1CYP11B2
SCHEMBL29293210 0.92 KDR (0.41) KDREGFRFGFR1CYP11B1CYP11B2
SCHEMBL29293160 0.88 CYP2A6 (0.48) CYP11B1CYP11B2CYP2A6DYRK1AALDH1A1
SCHEMBL29293207 0.88 KIF11 (0.48) CYP11B1CYP11B2CYP2A6DYRK1AALDH1A1
SCHEMBL29293114 0.86 KDR (0.42) KDREGFRFGFR1CYP11B1CYP11B2
SCHEMBL29293116 0.86 KDR (0.42) KDREGFRFGFR1CYP11B1CYP11B2
SCHEMBL29293345 0.85 NPY5R (0.46) CYP11B1CYP11B2NPY5RALDH1A1CYP1A2
SCHEMBL29293154 0.84 CYP2A6 (0.44) CYP11B1CYP11B2CYP2A6DYRK1AALDH1A1
SCHEMBL29293150 0.84 CYP11B1 (0.45) CYP11B1CYP11B2CYP2A6DYRK1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228470-A1 Organic Compound And Organic Light Emitting Device Including Same P&H TECH CO., LTD (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228470-A1 Organic Compound And Organic Light Emitting Device Including Same OR10J3, ORMDL3, OR51E2 KDR 1298/4885EGFR 3889/4885FGFR1 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback